TAG:
commercial laboratories
Unrealized Gains Targeted By Premier’s Lab Initiative
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: In part one of this exclusive interview, Premier’s John Biggers described the reasons why the 1,700 hospital consortium developed a strategic services program for clinical laboratories. In this final installment, Biggers provides insight as to how the program will work and …
Private Consortium Plans To Decode Human Genes
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Five years ago, the only option for mapping was to involve the government. New advancements in technology have lowered costs so radically that now private companies are willing to use their own funds to map the human genome. This brings the day ever closer when genetics-based…
Premier Explains Reasons It Sees Lab As Strategic
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Premier’s strategic alliance with Quest Diagnostics Incorporated represents a fundamental shift in the marketplace for hospital-based clinical laboratory services. This was a project developed by Premier, in response to its evaluation of marketplace trends affecting hospita…
Premier Executive John Biggers Discusses Reasons For Laboratory Initiative
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Because of Premier’s influence with 1,700 of the nation’s 5,000 hospitals, laboratory administrators and executives should realize that this strategic services alliance between Premier and Quest Diagnostics Incorporated will change traditional laboratory practices, regard…
New Alliance Is Example Of Coming Paradigm Shift
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: This strategic alliance represents a fundamental shift within the clinical laboratory industry. It is a response to market forces which should not be ignored by laboratory executives and pathologists anywhere in the country. Whether the alliance succeeds or fails, it will lau…
Hospital Lab-Commercial Lab Partnering Is Upcoming Trend
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: At this year’s Executive War College in New Orleans, laboratory innovators convened to study hot new trends in the industry.They were surprised to learn that partnering relationships between hospital laboratories and commercial laboratories are finally gaining wider accepta…
Where Do We Go From Here?
By R. Lewis Dark | From the Volume V No. 6 – May 4, 1998 Issue
THIS IS WRITTEN FOR BOTH LABORATORIANS COMING TO THE DARK REPORT’S Executive War College in New Orleans next week as well as those not attending. As I look at the registration list, I see a diverse range of attendees. Registered for this year’s event are CEOs of public laboratories and…
A Fable For Our Times: Lab Industry’s Golden Era
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
CEO SUMMARY: The clinical laboratory industry’s “Golden Era” is gone forever. Replacing it is a healthcare environment best described as “Darwinian.” It is now survival of the fittest, as hospital laboratories and commercial laboratories struggle to reinvent themselves. Case stu…
1997 LIS Sales Rankings Topped By Cerner, LabSoft
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
CEO SUMMARY: Consolidation in the LIS industry continued during 1997. The impact for laboratory buyers is that market share is concentrated among fewer vendors. Over the long term, this reduces choice and leads to an oligopoly-type of market. In the short-term, all LIS companies are compe…
Bio-Reference Labs Buys New York-Based Medilabs
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: Here is an independent commercial laboratory that shows sustained growth while it maintains profitable operations. One key strategy is the selective acquisition of laboratory business in small, profitable chunks. The sales price paid for Medilabs demonstrates how much decline…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized